Compass Pathways Plc (CMPS)
14.20
+0.87
(+6.53%)
USD |
NASDAQ |
Aug 24, 16:00
14.40
+0.20
(+1.41%)
After-Hours: 06:45
Compass Pathways Shareholders Equity (Quarterly) : 84.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.53M |
| March 31, 2026 | 326.69M |
| December 31, 2025 | -52.85M |
| September 30, 2025 | 37.59M |
| June 30, 2025 | 162.56M |
| March 31, 2025 | 195.47M |
| December 31, 2024 | 154.70M |
| September 30, 2024 | 193.03M |
| June 30, 2024 | 226.27M |
| March 31, 2024 | 259.16M |
| December 31, 2023 | 225.74M |
| September 30, 2023 | 253.26M |
| June 30, 2023 | 166.40M |
| Date | Value |
|---|---|
| March 31, 2023 | 161.64M |
| December 31, 2022 | 181.28M |
| September 30, 2022 | 194.56M |
| June 30, 2022 | 224.58M |
| March 31, 2022 | 259.57M |
| December 31, 2021 | 284.41M |
| September 30, 2021 | 305.42M |
| June 30, 2021 | 327.36M |
| March 31, 2021 | 188.50M |
| December 31, 2020 | 196.56M |
| September 30, 2020 | 203.08M |
| June 30, 2020 | 71.64M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 38.47M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 26.89M |
| Mereo BioPharma Group Plc | 28.65M |
| HemoGenyx Pharmaceuticals Plc | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.56M |
| Total Liabilities (Quarterly) | 420.03M |
| Debt to Equity Ratio | 0.6462 |
| Current Ratio | 1.295 |
| Net Debt Paydown Yield | -0.24% |